# Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors

> **NCT00730483** · NA · TERMINATED · sponsor: **Yale University** · enrollment: 13 (actual)

## Conditions studied

- Gastrointestinal Carcinoid Tumor
- Islet Cell Tumor
- Metastatic Cancer

## Interventions

- **DRUG:** PVA microporous hydrospheres/doxorubicin hydrochloride

## Key facts

- **NCT ID:** NCT00730483
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** High incidence of biloma and liver abscess after TACE
- **Last updated:** 2017-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00730483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00730483, "Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00730483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*